NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Queen’s leading clinical trial to examine drug effectiveness for critically-ill ICU patients

By Irish Pharmacist - 05th Jan 2021

In the Hospital Sick Male Patient Sleeps on the Bed. Heart Rate Monitor Equipment is on His Finger.

A new clinical trial led by Queen’s University Belfast will investigate different drugs for helping airway clearance in critically-ill patients who are on mechanical ventilators.  Researchers funded by the National Institute for Health Research (NIHR) will deliver a clinical trial aiming to recruit approximately 2,000 patients across the UK in order to determine the effectiveness of different treatments for supporting the management of patients with acute respiratory failure receiving mechanical ventilation. 

A common problem that patients receiving mechanical ventilation can experience is thick secretions in the airways, which can be difficult to clear and make the ventilation process harder. The MARCH trial will compare different drugs for managing thick secretions. These drugs will be compared individually, as well as in combination, with standard care. Using drugs to help airway clearance may reduce the duration of time for which patients require mechanical ventilation. 

The two drugs under investigation (carbocisteine and hypertonic saline) are commonly used at present in intensive care units (ICUs) across the UK, but it is not known which approach to their use is most effective. The comparative data produced by the trial will improve understanding of which, if either, of the drugs are most effective at improving patient outcomes. 

The opportunity to join the trial will be offered to all patients receiving mechanical ventilation in ICU and who have problems with thick secretions. ICUs across Northern Ireland, England, Scotland, and Wales will take part. The trial will provide patients with an equal chance of receiving standard care or any of the drug treatments. Which treatment the patient will receive will be decided by a computer at random and patients will receive all other treatments recommended by their clinical team. 

The trial is important for optimising the way in which patients in the ICU receiving mechanical ventilation are managed, and for reducing the delivery of potentially ineffective medications, said a statement from the University. 

Dr Bronwen Connolly, Chief Investigator for the trial from The Wellcome-Wolfson Institute for Experimental Medicine at Queen’s University said:

“Investigating treatments through clinical trials is the safest and most appropriate method for determining their effect. At present, we do not know whether these drugs are helpful for critically-ill patients receiving mechanical ventilation. This trial offers us the opportunity to carefully test these drugs and use the knowledge we gain to improve patient care.” 

“… The trial team comprises of multi-professional experts across critical care medicine, physiotherapy, pharmacy and nursing, with world-class expertise in the delivery of clinical trials to critically-ill patients with acute respiratory failure.” 

The MARCH trial will formally commence in February 2021. Further information can be found at: https://www.fundingawards.nihr.ac.uk/award/NIHR130454.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist May 2024

Irish Pharmacist May 2024. Volume 25 | Issue 5 | May 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT